Con esta herramienta te facilitamos un acceso a todas las ofertas y demandas de tecnología europeas y a búsquedas de socios para participar en propuestas europeas de I+D publicadas en la red Enterprise Europe Network, pudiendo filtrar los resultados para facilitar las búsquedas más acordes con tus necesidades.

¿Quieres recibir estos listados de oportunidades de colaboración en tu correo de forma periódica y personalizada? Date de alta en nuestro Boletín

Para optimizar los resultados de la búsqueda, se recomienda utilizar términos en inglés.

Empresa china busca una tecnología de detección del cáncer de vejiga mediante estudios de biopsia líquida

Resumen

Tipo:
Demanda Tecnológica
Referencia:
TRCN20181019004
Publicado:
18/12/2018
Caducidad:
19/12/2019
Resumen:
Una empresa china fundada en 2014 y especializada en detección de enfermedades y oncogenes, cuyos principales servicios incluyen la detección no invasiva de oncogenes, computación biológica, gestión de grandes volúmenes de datos y chips genéticos, busca tecnologías de detección del cáncer de vejiga. Específicamente busca un método de detección no invasiva, que utilice solo sangre u orina, que no requiera cirugía ni biopsia por punción y que a la vez se caracterice por la sensibilidad y especificidad en la detección de tejidos. La empresa busca socios con el fin de establecer acuerdos de investigación y cooperación técnica.

Details

Tittle:
A Chinese company is looking for a technology to detect bladder cancer through the studies on liquid biopsy.
Summary:
A Chinese genetic disease and oncogene detection company is looking for technologies to detect bladder cancer. A non-invasive detection, only using blood or urine, is sought, and with no surgery or puncture biopsy required, while achieving tissue detection sensitivity and specificity.
They want to cooperate with partners through research cooperation agreement and technical cooperation agreement.
Description:
The company which established in 2014, is located in Changsha City, Hunan Province.

The company dedicates to develop genetic disease and oncogene detection, and develop world-class biochip, providing genetic information big data and health management solutions. Founded in 2014, the company´s main products (services) include susceptible, non-invasive oncogene detection, biological computing, big data management and gene chip.
Traditionally, it usually uses tissue specimens for detection (biopsy), but there are certain limitations in tissue specimen detection, such as the inability of taking surgical samples from patients in late stage, poor tolerance to repeat biopsy, and heterogeneity of tumor tissues.
The company wonders if there is non-invasive detection (only use blood or urine, and no surgery or puncture biopsy is required), while achieving tissue detection sensitivity and specificity.

They are looking for a technology to detect bladder cancer.
They want to cooperate with partners through research cooperation agreement and technical cooperation agreement, buying either existing technologies for adaptation into detection, or research into ways to development the bladder cancer detection.
Technical Specification or Expertise Sought:

Studies on liquid biopsy will be carried out on three types of liquid biopsy: circulating tumor DNA (ctDNA), circulating tumor cells and exosomes.

Partner sought

Type and Role of Partner Sought:
They want to cooperate with partners through research cooperation agreement and technical cooperation agreement, buying either existing technologies for adaptation into detection, or research into ways to development the bladder cancer detection.

Client

Type and Size of Client:
Industry SME 50-249
Already Engaged in Trans-National Cooperation:
Si
Languages Spoken:
Chinese
English